Neyssa Marina
Publication Details
-
Refining therapeutic strategies for patients with resistant Wilm's tumor.
Am J Pediatr Hematol Oncol. 1994; (4): 296-300
Despite the excellent prognosis for 90% of patients with Wilms' tumor, survival remains poor among those with recurrent or advanced disease or tumors of unfavorable histology. We sought to identify a chemotherapy regimen for this subset of patients that offers potential efficacy with minimal nephrotoxicity.
Help
Trial Administration